Cited by 880Sarcoma Diagnosis and TreatmentChromatin Remodeling and CancerAcute Lymphoblastic Leukemia research

The DOI matches its Crossref record; 251 of the 251 references it cites were found in a registry or an index.

Ewing sarcoma

Grünewald, Thomas G. P., Cidre-Aranaz, Florencia, Surdez, Didier, Tomazou, Eleni M., de Álava, Enrique, Kovar, Heinrich, Sorensen, Poul H., Delattre, Olivier, Dirksen, Uta·2018·Nature Reviews Disease Primers

DOI 10.1038/s41572-018-0003-x

Open this paper in CoChat — free account

Abstract

Ewing sarcoma is the second most frequent bone tumour of childhood and adolescence that can also arise in soft tissue. Ewing sarcoma is a highly aggressive cancer, with a survival of 70-80% for patients with standard-risk and localized disease and ~30% for those with metastatic disease. Treatment comprises local surgery, radiotherapy and polychemotherapy, which are associated with acute and chronic adverse effects that may compromise quality of life in survivors. Histologically, Ewing sarcomas are composed of small round cells expressing high levels of CD99. Genetically, they are characterized by balanced chromosomal translocations in which a member of the FET gene family is fused with an ETS transcription factor, with the most common fusion being EWSR1-FLI1 (85% of cases). Ewing sarcoma breakpoint region 1 protein (EWSR1)-Friend leukaemia integration 1 transcription factor (FLI1) is a tumour-specific chimeric transcription factor (EWSR1-FLI1) with neomorphic effects that massively rewires the transcriptome. Additionally, EWSR1-FLI1 reprogrammes the epigenome by inducing de novo enhancers at GGAA microsatellites and by altering the state of gene regulatory elements, creating a unique epigenetic signature. Additional mutations at diagnosis are rare and mainly involve STAG2, TP53 and CDKN2A deletions. Emerging studies on the molecular mechanisms of Ewing sarcoma hold promise for improvements in early detection, disease monitoring, lower treatment-related toxicity, overall survival and quality of life.

Integrity signals

Registry

Crossref · 10.1038/s41572-018-0003-x

Cites

251 of 251 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED ARTICLE: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation
Javaheri, T., Kazemi, Z., Pěnčík, J., Pham, H. T., Kauer, M. O., Noorizadeh, R., Sax, B., Nivarthi, H., Schlederer, M., Maurer, B., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.268 · Cited by 18
Self-citation
Retracted
Bone marrow transplant
Szer, J. (1999) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb127745.x · Cited by 3,373
Histone methylation: a dynamic mark in health, disease and inheritance
Greer, E. L., & Shi, Y. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3173 · Cited by 2,241
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907
Self-citation
Targeting EZH2 in cancer
Kim, K. H., & Roberts, C. W. M. (2016) · Nature Medicine · doi:10.1038/nm.4036 · Cited by 1,471
Germline Mutations in Predisposition Genes in Pediatric Cancer
Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1508054 · Cited by 1,345
MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells
Xu, N., Papagiannakopoulos, T. Y., Pan, G., Thomson, J. A., & Kosik, K. S. (2009) · Cell · doi:10.1016/j.cell.2009.02.038 · Cited by 1,160
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
Shi, J., & Vakoc, C. R. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.05.016 · Cited by 888
Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics
Kadoch, C., & Crabtree, G. R. (2015) · Science Advances · doi:10.1126/sciadv.1500447 · Cited by 877
JHDM2A, a JmjC-Containing H3K9 Demethylase, Facilitates Transcription Activation by Androgen Receptor
Yamane, K., Toumazou, C., Tsukada, Y.-I., Erdjument‐Bromage, H., Tempst, P., Wong, J., & Zhang, Y. (2006) · Cell · doi:10.1016/j.cell.2006.03.027 · Cited by 860

Show all 250 references

Research works printed but not linked: 8

Ewing, J. Diffuse endothelioma of bone. Proc. N. Y. Pathol. Soc. 21, 17 (1921).
Lessnick, S. L., Braun, B. S., Denny, C. T. & May, W. A. Multiple domains mediate transformation by the Ewing’s sarcoma EWS/FLI-1 fusion gene. Oncogene 10, 423–431 (1995).
Ohno, T., Rao, V. N. & Reddy, E. S. EWS/Fli-1 chimeric protein is a transcriptional activator. Cancer Res. 53, 5859–5863 (1993).
Pizzo, P. A. & Poplack, D. G. (eds) Principles and Practice of Pediatric Oncology 7th edn (Lippincott Wililiams & Wilkins, Philadelphia, 2015).
ESMO/European Sarcoma Network Working Group. Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 25 (Suppl 3), iii113–iii123 (2014).
Machado, I., López-Guerrero, J. A., Scotlandi, K., Picci, P. & Llombart-Bosch, A. Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing’s sarcoma family of tumors (ESFT). Virchows Arch. Int. J. Pathol. 472, 815–824 (2018).
Wang, Y. X. et al. Inhibiting platelet-derived growth factor beta reduces Ewing’s sarcoma growth and metastasis in a novel orthotopic human xenograft model. In Vivo 23, 903–909 (2009).
Bhan, A. & Mandal, S. S. LncRNA HOTAIR: a master regulator of chromatin dynamics and cancer. Biochim. Biophys. Acta 1856, 151–164 (2015).

Sorted by citations

Items 201–300 of 880

The Role of Tyrosine Kinases as a Critical Prognostic Parameter and Its Targeted Therapies in Ewing Sarcoma
Jin, W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00613 · Cited by 17
Phase-Separated Subcellular Compartmentation and Related Human Diseases
Zhang, L., Wang, S., Wang, W., Shi, J., Stovall, D. B., Li, D., & Sui, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105491 · Cited by 18
Management of Refractory Pediatric Sarcoma: Current Challenges and Future Prospects
Pushpam, D., Garg, V., Ganguly, S., & Biswas, B. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s193363 · Cited by 16
Synergistic anticancer activity of combined ATR and ribonucleotide reductase inhibition in Ewing's sarcoma cells
Sturm, M.-J., Henao-Restrepo, J. A., Becker, S., Proquitté, H., Beck, J. F., & Sonnemann, J. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04804-0 · Cited by 16
Circumventing resistance within the Ewing sarcoma microenvironment by combinatorial innate immunotherapy
Luo, W., Hoang, H., Zhu, H., Miller, K. E., Mo, X. M., Eguchi, S., Tian, M., Liao, Y., Ayello, J., Rosenblum, J., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009726 · Cited by 16
Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways
Nan, X., Wang, J., Cheng, H., Yin, Z., Sheng, J., Qiu, B., Lau, C. C., Yustein, J. T., Zhao, H., & Wong, S. T. C. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.10.034 · Cited by 15
Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma
Sciandra, M., Feo, A. D., Parra, A., Landuzzi, L., Lollini, P., Manara, M. C., Mattia, G., Pontecorvi, G., Baricordi, C., Guerzoni, C., et al. (2020) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-020-00567-2 · Cited by 16
Eltrombopag inhibits the proliferation of Ewing sarcoma cells via iron chelation and impaired DNA replication
Waters, T. W., Goss, K. L., Koppenhafer, S. L., Terry, W. W., & Gordon, D. J. (2020) · BMC Cancer · doi:10.1186/s12885-020-07668-6 · Cited by 16
Number of metastases and their response to chemotherapy impact survival of patients with isolated lung metastases from bone-derived sarcoma
Störk, T., Boemans, R., Hardes, J., Streitbürger, A., Dirksen, U., Pöttgen, C., Schildhaus, H., Bauer, S., Collaud, S., & Aigner, C. (2021) · BMC Cancer · doi:10.1186/s12885-021-08073-3 · Cited by 16
Self-citation
CD44 Modulates Cell Migration and Invasion in Ewing Sarcoma Cells
Fernández-Tabanera, E., García‐García, L., Rodriguez‐Martin, C., Cervera, S. T., González‐González, L., Robledo, C., Josa, S., Martínez, S., Chapado, L. A., Monzón, S., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411774 · Cited by 16
Organoids as a new approach for improving pediatric cancer research
Lampis, S., Galardi, A., Paolo, V. D., & Giannatale, A. D. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1414311 · Cited by 16
Prospective Clinical Genomic Profiling of Ewing Sarcoma: ERF and FGFR1 Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance
Ogura, K., Elkrief, A., Bowman, A. S., Koche, R. P., de Stanchina, E., Benayed, R., Mauguen, A., Mattar, M. S., Khodos, I., Meyers, P. A., et al. (2022) · JCO Precision Oncology · doi:10.1200/po.22.00048 · Cited by 15
Optimisation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as novel Hsp90 C-terminal domain inhibitors against Ewing sarcoma
Zajec, Ž., Dernovšek, J., Distel, M., Gobec, M., & Tomašič, T. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106311 · Cited by 15
Effect of Radiotherapy Dose on Outcome in Nonmetastatic Ewing Sarcoma
Kersting, J., Ranft, A., Bhadri, V. A., Brichard, B., Collaud, S., Cyprová, S., Eich, H. T., Ek, T., Gelderblom, H. A. J., Hardes, J., et al. (2023) · Advances in Radiation Oncology · doi:10.1016/j.adro.2023.101269 · Cited by 15
Self-citation
Targeting DNA Methylation Machinery in Pediatric Solid Tumors
Cristalli, C., & Scotlandi, K. (2024) · Cells · doi:10.3390/cells13141209 · Cited by 14
Genetic Characterization of Pediatric Sarcomas by Targeted RNA Sequencing
Avenarius, M. R., Miller, C. R., Arnold, M., Koo, S. C., Roberts, R. D., Hobby, M., Grossman, T., Moyer, Y., Wilson, R. K., Mardis, E. R., et al. (2020) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2020.07.004 · Cited by 15
(Immuno)histological Analysis of Ewing Sarcoma
Marcilla, D., Machado, I., Grünewald, T. G. P., Civantos, G., Llombart-Bosch, A., & de Álava, E. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1020-6_5 · Cited by 15
Self-citation
PDX-Derived Ewing’s Sarcoma Cells Retain High Viability and Disease Phenotype in Alginate Encapsulated Spheroid Cultures
Domenici, G., Eduardo, R., Castillo‐Ecija, H., Orive, G., Carcaboso, A. M., & Brito, C. (2021) · Cancers · doi:10.3390/cancers13040879 · Cited by 15
Skin Toxicity Profile of Photon Radiotherapy versus Proton Beam Therapy in Paediatric and Young Adult Patients with Sarcomas
Gaito, S., Abravan, A., Richardson, J., Lowe, M., Indelicato, D. J., Burnet, N. G., & Smith, E. (2021) · Clinical Oncology · doi:10.1016/j.clon.2021.03.009 · Cited by 15
Mitochondrial Dysfunction Is a Driver of SP-2509 Drug Resistance in Ewing Sarcoma
Tokarsky, E. J., Crow, J. C., Guenther, L. M., Sherman, J. W., Taslim, C., Alexe, G., Pishas, K. I., Rask, G. C., Justis, B. S., Kasumova, A., et al. (2022) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0027 · Cited by 14
Novel Targeting of DNA Methyltransferase Activity Inhibits Ewing Sarcoma Cell Proliferation and Enhances Tumor Cell Sensitivity to DNA Damaging Drugs by Activating the DNA Damage Response
Cristalli, C., Manara, M. C., Valente, S., Pellegrini, E., Bavelloni, A., Feo, A. D., Blalock, W. L., Bello, E. D., Piñeyro, D., Merkel, A., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.876602 · Cited by 15
Precision Medicine Highlights Dysregulation of the CDK4/6 Cell Cycle Regulatory Pathway in Pediatric, Adolescents and Young Adult Sarcomas
Barghi, F., Shannon, H. E., Saadatzadeh, M. R., Bailey, B. J., Riyahi, N., Bijangi‐Vishehsaraei, K., Just, M., Ferguson, M. J., Pandya, P. H., & Pollok, K. E. (2022) · Cancers · doi:10.3390/cancers14153611 · Cited by 15
In vivo 3D profiling of site-specific human cancer cell morphotypes in zebrafish
Segal, D., Mazloom-Farsibaf, H., Chang, B.-J., Roudot, P., Rajendran, D., Daetwyler, S., Fiolka, R. P., Warren, M., Amatruda, J. F., & Danuser, G. M. (2022) · The Journal of Cell Biology · doi:10.1083/jcb.202109100 · Cited by 15
Grb2-associated binding protein-1 as a biomarker in bone and soft tissue sarcomas
Al‐Husseinawi, E., Bui, M. M., & Ahmed, A. A. (2019) · Pathology · doi:10.1016/j.pathol.2019.05.003 · Cited by 14
Sarcomas in Teachers Using Three-Dimensional Printers: A Report of Three Patients and Literature Review
Joo, M. W., Lee, Y.-S., Chung, Y., & Lee, H. K. (2022) · Clinics in Orthopedic Surgery · doi:10.4055/cios21181 · Cited by 14
Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial
Koch, R., Haveman, L., Ladenstein, R. L., Brichard, B., Jürgens, H., Cyprová, S., van den Berg, H., Hassenpflug, W. A., Raciborska, A., Ek, T., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-1966 · Cited by 14
Self-citation
Prognostic and predictive biomarkers in paediatric solid tumours
Glembocki, A. I., & Somers, G. R. (2023) · Pathology · doi:10.1016/j.pathol.2023.11.007 · Cited by 14
Cellular toxicology and mechanism of the response to silver-based nanoparticle exposure in Ewing’s sarcoma cells
Ferreira, V. D. S., Eugênio, M., Nery, E. D., de Souza, W., & Sant’Anna, C. (2020) · Nanotechnology · doi:10.1088/1361-6528/abcef3 · Cited by 14
DLX6-AS1 is a potential biomarker and therapeutic target in cancer initiation and progression
Zheng, Q., Gu, X., Yang, Q., Chu, Q., Dai, Y., & Chen, Z. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.02.006 · Cited by 14
EWS-FLI1 and Menin Converge to Regulate ATF4 Activity in Ewing Sarcoma
Jiménez, J. A., Apfelbaum, A. A., Hawkins, A. G., Svoboda, L. K., Kumar, A., Ocádiz-Ruiz, R., Garcia, A. X., Haarer, E. L., Nwosu, Z. C., Bradin, J., et al. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0679 · Cited by 14
POU2AF3 ‐rearranged sarcomas: A novel tumor defined by fusions of EWSR1 or FUS to a gene formerly designated COLCA2
Hiemenz, M., Kaur, J., Kuang, Z., Huang, R. S. P., Harries, L., Metzger, D., Schiavone, K., Millis, S. Z., Lin, D. I., Lechpammer, M., et al. (2023) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23136 · Cited by 14
An Updated Review of the Anticancer Mechanisms and Therapeutic Potential of Naringenin
Noman, A. M., Sultan, M. T., Raza, H., Imran, M., Hussain, M., Mujtaba, A., Mostafa, E. M., Ghoneim, M. M., Selim, S., Jaouni, S. K. A., et al. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70626 · Cited by 13
Genetic Alterations and Deregulation of Hippo Pathway as a Pathogenetic Mechanism in Bone and Soft Tissue Sarcoma
Salguero‐Aranda, C., Olmedo-Pelayo, J., de Álava, E., Amaral, A. T., & Díaz‐Martín, J. (2022) · Cancers · doi:10.3390/cancers14246211 · Cited by 12
Identification of Novel/Rare EWSR1 Fusion Partners in Undifferentiated Mesenchymal Neoplasms
Salguero‐Aranda, C., Blasi, E. D., Galán, L. A., Zaldumbide, L., Civantos, G., Marcilla, D., de Álava, E., & Díaz‐Martín, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031735 · Cited by 13
Oncogenic ETS fusions promote DNA damage and proinflammatory responses via pericentromeric RNAs in extracellular vesicles
Ruzanov, P., Evdokimova, V. E., Pachva, M. C., Minkovich, A., Zhang, Z., Langman, S., Gassmann, H., Thiel, U., Orlic-Milacic, M., Zaidi, S. H. E., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci169470 · Cited by 15
Self-citation
Primary Bone Tumors and Breast Cancer-Induced Bone Metastases: In Vivo Animal Models and New Alternative Approaches
Ucci, A., Giacchi, L., & Rucci, N. (2024) · Biomedicines · doi:10.3390/biomedicines12112451 · Cited by 14
Extraskeletal Ewing Sarcoma of the Jejunum: A Case Report
Cantu, C. A., Bressler, E. L., Dermawan, J. K. T. K., & Paral, K. M. (2019) · The Permanente Journal · doi:10.7812/tpp/18-255 · Cited by 13
The Transcription Factor FEZF1, a Direct Target of EWSR1-FLI1 in Ewing Sarcoma Cells, Regulates the Expression of Neural-Specific Genes
García‐García, L., Fernández-Tabanera, E., Cervera, S. T., de Mera, R. M. M.-F., Josa, S., González‐González, L., Rodriguez‐Martin, C., Grünewald, T. G. P., & Alonso, J. (2021) · Cancers · doi:10.3390/cancers13225668 · Cited by 13
Self-citation
Mutational landscape of primary and recurrent Ewing sarcoma
Jagodzińska-Mucha, P., Sobczuk, P., Mikuła, M., Raciborska, A., Dawidowska, A., Kulecka, M., Bilska, K., Szumera‐Ciećkiewicz, A., Kluska, A., Piątkowska, M., et al. (2021) · Współczesna Onkologia · doi:10.5114/wo.2021.112234 · Cited by 14
Cancer Stem Cells and Chemoresistance in Ewing Sarcoma
dos Santos, R. P., Roesler, R., Gregianin, L. J., Brunetto, A. T., Jaeger, M. D. C., Brunetto, A. L., & de Farias, C. B. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x17666220627114710 · Cited by 13
Endoglin and MMP14 Contribute to Ewing Sarcoma Spreading by Modulation of Cell–Matrix Interactions
Puerto‐Camacho, P., Díaz‐Martín, J., Olmedo-Pelayo, J., Bolado‐Carrancio, A., Salguero‐Aranda, C., Jordán-Pérez, C., Esteban‐Medina, M., Álamo-Álvarez, I., Delgado‐Bellido, D., Lobo-Selma, L., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158657 · Cited by 13
Self-citation
Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies
Sánchez-Molina, S., Figuerola-Bou, E., Sánchez‐Margalet, V., de la Cruz‐Merino, L., Mora, J., de Álava, E., García-Domínguez, D. J., & Hontecillas‐Prieto, L. (2022) · Cancers · doi:10.3390/cancers14215473 · Cited by 14
A seven-lncRNA signature for predicting Ewing’s sarcoma
Chen, Z., Wang, X., Wang, G., Xiao, B., Ma, Z., Huo, H., & Li, W. (2021) · PeerJ · doi:10.7717/peerj.11599 · Cited by 13
Oxidative and Antioxidative Status Expressed as OSI Index and GSH/GSSG Ratio in Children with Bone Tumors after Anticancer Therapy Completion
Gajewska, J., Chełchowska, M., Rychłowska-Pruszyńska, M., Klepacka, T., & Ambroszkiewicz, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11061663 · Cited by 13
Acetylation dependent translocation of EWSR1 regulates CHK2 alternative splicing in response to DNA damage
Zhang, T., Wang, Z., Liu, M., Liu, L., Yang, X. P., Zhang, Y., Bie, J., Li, Y., Ren, M., Song, C., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02383-x · Cited by 12
Effects of an Exercise Intervention on Gait Function in Young Survivors of Osteosarcoma with Megaendoprosthesis of the Lower Extremity—Results from the Pilot Randomized Controlled Trial proGAIT
Basteck, S., Guder, W. K., Dirksen, U., Krombholz, A., Streitbürger, A., Reinhardt, D., & Götte, M. (2022) · Current Oncology · doi:10.3390/curroncol29100613 · Cited by 12
Self-citation
Sarcoma_CellminerCDB: A tool to interrogate the genomic and functional characteristics of a comprehensive collection of sarcoma cell lines
Tlemsani, C., Heske, C. M., Elloumi, F., Pongor, L. S., Khandagale, P., Varma, S., Luna, A., Meltzer, P. S., Khan, J. I., Reinhold, W. C., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109781 · Cited by 10
The survival disparity between children and adolescents and young adults (AYAs) with Ewing sarcoma in the Netherlands did not change since the 1990s despite improved survival: A population-based study
Schulpen, M., Haveman, L., van der Heijden, L., Kaal, S. E. J., Bramer, J. A. M., Fajardo, R. D., de Haan, J. J., Hiemcke‐Jiwa, L. S., ter Horst, S. A. J., Jutte, P. C., et al. (2024) · European Journal of Cancer · doi:10.1016/j.ejca.2024.114209 · Cited by 12
Genomic and phenotypic stability of fusion-driven pediatric sarcoma cell lines
Kasan, M., Geyer, F. H., Siebenlist, J., Sill, M., Öllinger, R., Faehling, T., de Álava, E., Surdez, D., Dirksen, U., Oehme, I., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55340-5 · Cited by 13
Self-citation
Reverse Engineering of Ewing Sarcoma Regulatory Network Uncovers PAX7 and RUNX3 as Master Regulators Associated with Good Prognosis
Ribeiro-Dantas, M. D. C., Imparato, D. O., Dalmolin, M., de Farias, C. B., Brunetto, A. T., Jaeger, M. D. C., Roesler, R., Sinigaglia, M., & Dalmolin, R. J. S. (2021) · Cancers · doi:10.3390/cancers13081860 · Cited by 12
E2F1 promotes Warburg effect and cancer progression via upregulating ENO2 expression in Ewing sarcoma
Jiang, X., Chen, Z., Zhu, J., Han, J., You, G., Li, Y., Liu, T., & Ye, H. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12753 · Cited by 13
WEE1 Inhibition Augments CDC7 (DDK) Inhibitor–induced Cell Death in Ewing Sarcoma by Forcing Premature Mitotic Entry and Mitotic Catastrophe
Martin, J. C., Sims, J. R., Gupta, A. K., Bakin, A. V., & Ohm, J. E. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0130 · Cited by 12
Activator Protein-1 (AP-1) Signaling Inhibits the Growth of Ewing Sarcoma Cells in Response to DNA Replication Stress
Croushore, E. E., Koppenhafer, S. L., Goss, K. L., Geary, E. L., & Gordon, D. J. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0268 · Cited by 12
Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trial
Heesen, P., Ranft, A., Bhadri, V. A., Brichard, B., Collaud, S., Cyprová, S., Eich, H. T., Ek, T., Gelderblom, H. A. J., Hardes, J., et al. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2023.113260 · Cited by 12
Self-citation
Pediatric peripheral nerve tumors: clinical and surgical aspects
Guedes, F., Brown, R. S., Torrão, F., Barbosa, D. A. N., Ravanini, G. D. A. G., & Amorim, R. M. P. (2019) · Child s Nervous System · doi:10.1007/s00381-019-04306-w · Cited by 12
Interaction between somatic mutations and germline variants contributes to clinical heterogeneity in cancer
Musa, J., & Grünewald, T. G. P. (2019) · Molecular & Cellular Oncology · doi:10.1080/23723556.2019.1682924 · Cited by 12
Self-citation
Clinical characteristics and treatment‐associated survival of head and neck Ewing sarcoma
Torabi, S. J., Izreig, S., Kasle, D. A., Benchetrit, L., Salehi, P. P., & Judson, B. L. (2019) · The Laryngoscope · doi:10.1002/lary.28412 · Cited by 12
Systematic target actionability reviews of preclinical proof-of-concept papers to match targeted drugs to paediatric cancers
Schubert, N. A., Lowery, C. D., Bergthold, G., Köster, J., Eleveld, T. F., Rodríguez, A. I. E., Jones, D., Vassal, G., Stancato, L. F., Pfister, S. M., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.01.027 · Cited by 12
Identification of malignant cells in single-cell transcriptomics data
Andreatta, M., Garnica, J., & Carmona, S. J. (2025) · Communications Biology · doi:10.1038/s42003-025-08695-4 · Cited by 13
Secondary Malignancies after Ewing Sarcoma—Epidemiological and Clinical Analysis of an International Trial Registry
Kaiser, I., Kauertz, K. L., Zöllner, S. K., Hartmann, W., ten Langer, T. S., Jürgens, H., Ranft, A., & Dirksen, U. (2022) · Cancers · doi:10.3390/cancers14235920 · Cited by 10
Self-citation
Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding
Lee, O. W., Rodrigues, C., Lin, S., Luo, W., Jones, K. M., Brown, D. W., Zhou, W., Karlins, E., Khan, S. M., Baulande, S., et al. (2023) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.01.017 · Cited by 10
Self-citation
Ewing's sarcoma of the head and neck: A systematic review
Spiguel, M. H., Schuch, L. F., Kovalski, L. N. S., Ribeiro, J. T., Só, B. B., Silveira, F. M., Vargas, P. A., Martins, M. A. T., Zanella, V. G., Aleixo, P. B., et al. (2023) · Oral Diseases · doi:10.1111/odi.14644 · Cited by 11
Signaling pathways and targeted therapies in Ewing sarcoma
Jia, K., Cao, L., Yu, Y., Jing, D., Wu, W., Tine, B. A. V., & Shao, Z. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108765 · Cited by 15
EWS-FLI1 low Ewing sarcoma cells demonstrate decreased susceptibility to T-cell-mediated tumor cell apoptosis
Bailey, K. M., Julian, C. M., Klinghoffer, A. N., Bernard, H., Lucas, P. C., & McAllister‐Lucas, L. M. (2019) · Oncotarget · doi:10.18632/oncotarget.26939 · Cited by 11
miR-214-3p Is Commonly Downregulated by EWS-FLI1 and by CD99 and Its Restoration Limits Ewing Sarcoma Aggressiveness
Feo, A. D., Pazzaglia, L., Ciuffarin, L., Mangiagli, F., Pasello, M., Simonetti, E., Pellegrini, E., Ferrari, C., Bianchi, G., Spazzoli, B., et al. (2022) · Cancers · doi:10.3390/cancers14071762 · Cited by 11
Zooming in on Long Non-Coding RNAs in Ewing Sarcoma Pathogenesis
Aryee, D. N. T., Fock, V., Kapoor, U., Radic-Sarikas, B., & Kovar, H. (2022) · Cells · doi:10.3390/cells11081267 · Cited by 11
Self-citation
Drug Screening by Resazurin Colorimetry in Ewing Sarcoma
Musa, J., & Cidre‐Aranaz, F. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1020-6_12 · Cited by 11
Self-citation
Primary gastric Ewing sarcoma/primitive neuroectodermal tumor
Ye, Y., Qiu, X., Mei, J., He, D., & Zou, A. (2021) · Journal of International Medical Research · doi:10.1177/0300060520986681 · Cited by 11
Dose Intensification Improves the Outcome of Ewing Sarcoma
Gorlick, R. G., Janeway, K. A., & Adamson, P. C. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.79.3489 · Cited by 11
Trends in malignant neoplasm of bone and articular cartilage related mortality among older adults in United States (1999–2020)
Haseeb, A., Nasrullah, R. M. U., Siddiq, M. A., Rahman, H. A. U., Ali, S. M. S., Advani, D., Kumar, L., Shafique, M. A., Mustafa, M. S., Raja, S., et al. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002629 · Cited by 10
TCF19 / CDKN2A Regulates Glycolysis and Macrophage M2 Polarization for Osteosarcoma Progression
Hu, X., Chen, W., Yang, K., Zhu, C., Li, Z., Zheng, D., & Geng, R. (2025) · The FASEB Journal · doi:10.1096/fj.202401343rrr · Cited by 10
ETS1 , a Target Gene of the EWSR1::FLI1 Fusion Oncoprotein, Regulates the Expression of the Focal Adhesion Protein TENSIN3
Ebegboni, V. J., Jones, T. L., Brownmiller, T., Zhao, P. X., Pehrsson, E. C., Rajan, S. S., & Caplen, N. J. (2024) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-23-1090 · Cited by 10
Survival outcomes in pediatric patients with metastatic Ewing sarcoma who achieve a rapid complete response of pulmonary metastases
Reiter, A. J., Huang, L. W., Craig, B. T., Davidoff, A. M., Talbot, L. J., Coggins, J., Smith, J., Aldrink, J. H., Bergus, K. C., MacArthur, T. A., et al. (2024) · Pediatric Blood & Cancer · doi:10.1002/pbc.31026 · Cited by 10
SETD8 inhibits apoptosis and ferroptosis of Ewing’s sarcoma through YBX1/RAC3 axis
Chen, H., Hu, J., Xiong, X., Chen, H., Liao, Q., Lin, B., Chen, Y., Peng, Y., Li, Y., Cheng, D., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06882-5 · Cited by 10
Incidence trends, overall survival, and metastasis prediction using multiple machine learning and deep learning techniques in pediatric and adolescent population with osteosarcoma and Ewing’s sarcoma: nomogram and webpage
Zhou, C., Li, H., Zeng, H., & Wang, P. (2024) · Clinical & Translational Oncology · doi:10.1007/s12094-024-03717-9 · Cited by 10
Fusion genes in cancers: Biogenesis, functions, and therapeutic implications
Tang, H., Qiu, P., Oyang, L., Tan, S., Jiang, X., Ren, Z., Xu, X., Shen, M., Li, H., Peng, M., et al. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101536 · Cited by 11
Refined culture conditions with increased physiological relevance uncover oncogene-dependent metabolic signatures in Ewing sarcoma spheroids
Ceranski, A. K., Carreño-Gonzalez, M. J., Ehlers, A. C., Hanssen, K. M., Gmelin, N., Geyer, F. H., Kolodynska, Z., Vinca, E., Faehling, T., Biechl, P., et al. (2025) · Cell Reports Methods · doi:10.1016/j.crmeth.2025.100966 · Cited by 10
Self-citation
YAP1 is a key regulator of EWS::FLI1-dependent malignant transformation upon IGF-1-mediated reprogramming of bone mesenchymal stem cells
Noorizadeh, R., Sax, B., Javaheri, T., Radic-Sarikas, B., Fock, V., Suresh, V., Kauer, M. O., Bykov, A., Kurija, D., Schlederer, M., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115381 · Cited by 11
Self-citation
Subversion of mRNA degradation pathways by EWSR1::FLI1 represents a therapeutic vulnerability in Ewing sarcoma
Galvan, B., Ongena, L., Bruyr, J., Fettweis, G., Lucarelli, E., Lavergne, A., Mariavelle, E., O’Grady, T. M., Hassoun, Z. E. O., Claes, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61725-x · Cited by 10
Self-citation
The 1H, 15N and 13C resonance assignments of the low-complexity domain from the oncogenic fusion protein EWS-FLI1
Johnson, C. N., Xu, X., Holloway, S. P., & Libich, D. S. (2022) · Biomolecular NMR Assignments · doi:10.1007/s12104-021-10061-4 · Cited by 10
Membrane‐type 1 matrix metalloproteinase as predictor of survival and candidate therapeutic target in Ewing sarcoma
Brookes, M. J., Roundhill, E. A., Jeys, L. M., Parry, M., Burchill, S. A., & Rankin, K. S. (2022) · Pediatric Blood & Cancer · doi:10.1002/pbc.29959 · Cited by 10
Neomorphic DNA-binding enables tumor-specific therapeutic gene expression in fusion-addicted childhood sarcoma
Hölting, T. L. B., Cidre‐Aranaz, F., Matzek, D., Popper, B., Jacobi, S. J., Funk, C. M., Geyer, F. H., Li, J., Piseddu, I., Cadilha, B. L., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01641-6 · Cited by 14
Self-citation
Natural Killer Cell Activation by Ubiquitin-specific Protease 6 Mediates Tumor Suppression in Ewing Sarcoma
Jain, K., Henrich, I. C., Quick, L., Young, R., Mondal, S., Oliveira, A. M., Blobel, G. A., & Chou, M. M. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0505 · Cited by 10
CRISPR-Cas9 knockout screening identifies KIAA1429 as an essential gene in Ewing sarcoma
Tan, K., Lu, W., Chen, F., Shi, H. S., Ma, Y., Chen, Z., Wu, W., Lv, Z., & Mo, J. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02828-5 · Cited by 12
Hedgehog pathway in sarcoma: from preclinical mechanism to clinical application
Banaszek, N., Kurpiewska, D., Kozak, K., Rutkowski, P. L., & Sobczuk, P. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05441-3 · Cited by 12
Suggested role for neutrophil extracellular trap formation in Ewing sarcoma immune microenvironment
Shukrun, R., Baron, S., Fidel, V., Shusterman, A., Sher, O., Kollender, N., Levin, D., Peled, Y., Gortzak, Y., Ben‐Shahar, Y., et al. (2023) · Cancer Science · doi:10.1111/cas.15992 · Cited by 12
A Nonpediatric Extraosseous Ewing Sarcoma of the Pancreas: Differential Diagnosis and Therapeutic Strategies
Yohannan, B., & Feldman, M. L. (2020) · Case Reports in Oncological Medicine · doi:10.1155/2020/2792750 · Cited by 10
Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma
Lin, S., Sampson, J. N., Grünewald, T. G. P., Surdez, D., Reynaud, S., Mirabeau, O., Karlins, E., Rubío, R. A., Zaïdi, S., Grossetête, S., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237792 · Cited by 11
Self-citation
Adding Perplexity to Rarity: Diffuse S100-Protein and SOX10 Expression in a Molecularly Confirmed PAX7-Positive Primary Cutaneous Ewing Sarcoma
Parra, O., Thuraisingam, R., Baker, M. L., Kerr, D. A., & Linos, K. D. (2021) · American Journal of Dermatopathology · doi:10.1097/dad.0000000000002000 · Cited by 10
Androgen signaling connects short isoform production to breakpoint formation at Ewing sarcoma breakpoint region 1
Nicholas, T. R., Metcalf, S. A., Greulich, B. M., & Hollenhorst, P. C. (2021) · NAR Cancer · doi:10.1093/narcan/zcab033 · Cited by 10
Extracellular Vesicles in Reprogramming of the Ewing Sarcoma Tumor Microenvironment
Pachva, M. C., Lai, H., Jia, A.-L., Rouleau, M., & Sorensen, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.726205 · Cited by 11
Self-citation
Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma
Jiang, W., Wu, T., Shi, X., & Xu, J. (2021) · Bioengineered · doi:10.1080/21655979.2021.1982844 · Cited by 10
Extracellular Vesicles: A New Source of Biomarkers in Pediatric Solid Tumors? A Systematic Review
Lak, N. S. M., van der Kooi, E. J., Enciso‐Martinez, A., Lozano−Andrés, E., Otto, C., Wauben, M. H. M., & Tytgat, G. A. M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.887210 · Cited by 10
The prognostic value of autophagy related genes with potential protective function in Ewing sarcoma
Wen, J., Wan, L., & Dong, X. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-04849-x · Cited by 10
Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells
Mancarella, C., Giusti, V., Caldoni, G., Laginestra, M. A., Parra, A., Toracchio, L., Giordano, G., Roncuzzi, L., Piazzi, M., Blalock, W. L., et al. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-023-00637-8 · Cited by 10
Fusion oncogenes—genetic musical chairs
Imielinski, M. B., & Ladanyi, M. (2018) · Science · doi:10.1126/science.aau8231 · Cited by 10
Effective combination of cold physical plasma and chemotherapy against Ewing sarcoma cells in vitro
Nitsch, A., Qarqash, S., Römer, S., Schoon, J., Singer, D., Bekeschus, S., Ekkernkamp, A., Wassilew, G. I., Tzvetkov, M. V., & Haralambiev, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-56985-4 · Cited by 9
Tyrosine kinase inhibitors in Ewing’s sarcoma: a systematic review
Assi, A., Farhat, M., Mohanna, R., Hachem, M. C. R., Zalaquett, Z., Aoun, M., Farraj, S. A., Daher, M., Sebaaly, A., & Kourié, H. R. (2025) · BMC Cancer · doi:10.1186/s12885-025-14130-y · Cited by 9
Epigenetic roles of chromatin remodeling complexes in bone biology and the pathogenesis of bone‑related disease (Review)
Wu, W., Cui, Y., Wu, Y., Ni, Y., Zhao, C., Sun, W., & Yi, Q. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5556 · Cited by 9
Patient-derived tumoroids from CIC::DUX4 rearranged sarcoma identify MCL1 as a therapeutic target
Breunis, W. B., Brack, E. K., Ehlers, A. C., Bechtold, I., Kisele, S., Wurth, J., Mous, L., Zabėlė, D., Steffen, F. D., Zahnow, F., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62629-6 · Cited by 10
Self-citation

Authors: Grünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U.
Affiliations: German Cancer Research Center (DE)
Inserm (FR)
St. Anna Children's Cancer Research Institute (AT)
University of British Columbia (CA)
Corresponding author: Grünewald, Thomas G. P.
ORCID: Grünewald, Thomas G. P.
Surdez, Didier
Tomazou, Eleni M.
Kovar, Heinrich
Sorensen, Poul H.
Delattre, Olivier
Dirksen, Uta
Venue: Nature Reviews Disease Primers
Publisher: Springer Science and Business Media LLC
Published: 2018-07-05
Volume: 4
Issue: 1
Pages: 5-5
ISSN: 2056-676X (ISSN-L)
DOI: 10.1038/s41572-018-0003-x
OpenAlex: W4211227438
Cited by: 873
References: 250
Citations by year: 2026: 114 · 2025: 155 · 2024: 104 · 2023: 103 · 2022: 158 · 2021: 115 · 2020: 66 · 2019: 49 · 2018: 8
FWCI: 10.61
Type: journal article
Language: en
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Disease Primers (publishedVersion)
PubMed (publishedVersion)
DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
Topics: Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
Keywords: Ewing sarcoma, EWSR1-FLI1 fusion, CD99, epigenetic reprogramming, STAG2 mutation, TP53 mutation, CDKN2A deletion, treatment toxicity, cancer survivorship, soft tissue sarcoma
MeSH terms: 12E7 Antigen, Humans, Neoplasm Metastasis, Quality of Life, Radiography, Risk Factors, Sarcoma, Ewing, RNA-Binding Protein EWS, Proto-Oncogene Protein c-fli-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Ewing sarcoma

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks